Titan wins FDA nod to study Parkinson’s implant

Titan Pharmaceuticals’ stated today that their ropinirole implant, designed to treat the symptoms of Parkinson’s disease, was cleared by the FDA today as a new drug application.

• Source: drugdeliverybusiness
• 654
• August 25, 2017